Reply to comments on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei”

Detalles Bibliográficos
Autores principales: Hiraide, Sakura, Komine, Keigo, Takahashi, Masanobu, Ishioka, Chikashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895766/
https://www.ncbi.nlm.nih.gov/pubmed/33547970
http://dx.doi.org/10.1007/s10147-021-01878-z
_version_ 1783653427319930880
author Hiraide, Sakura
Komine, Keigo
Takahashi, Masanobu
Ishioka, Chikashi
author_facet Hiraide, Sakura
Komine, Keigo
Takahashi, Masanobu
Ishioka, Chikashi
author_sort Hiraide, Sakura
collection PubMed
description
format Online
Article
Text
id pubmed-7895766
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-78957662021-03-03 Reply to comments on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei” Hiraide, Sakura Komine, Keigo Takahashi, Masanobu Ishioka, Chikashi Int J Clin Oncol Letter to the Editor Springer Singapore 2021-02-06 2021 /pmc/articles/PMC7895766/ /pubmed/33547970 http://dx.doi.org/10.1007/s10147-021-01878-z Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter to the Editor
Hiraide, Sakura
Komine, Keigo
Takahashi, Masanobu
Ishioka, Chikashi
Reply to comments on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei”
title Reply to comments on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei”
title_full Reply to comments on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei”
title_fullStr Reply to comments on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei”
title_full_unstemmed Reply to comments on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei”
title_short Reply to comments on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei”
title_sort reply to comments on “efficacy of modified folfox6 chemotherapy for patients with unresectable pseudomyxoma peritonei”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895766/
https://www.ncbi.nlm.nih.gov/pubmed/33547970
http://dx.doi.org/10.1007/s10147-021-01878-z
work_keys_str_mv AT hiraidesakura replytocommentsonefficacyofmodifiedfolfox6chemotherapyforpatientswithunresectablepseudomyxomaperitonei
AT kominekeigo replytocommentsonefficacyofmodifiedfolfox6chemotherapyforpatientswithunresectablepseudomyxomaperitonei
AT takahashimasanobu replytocommentsonefficacyofmodifiedfolfox6chemotherapyforpatientswithunresectablepseudomyxomaperitonei
AT ishiokachikashi replytocommentsonefficacyofmodifiedfolfox6chemotherapyforpatientswithunresectablepseudomyxomaperitonei

Ejemplares similares